[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cell Therapy and Acellular Therapy Market, Global Outlook and Forecast 2022-2028

June 2022 | 64 pages | ID: C2DBA655F30DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cell Therapy and Acellular Therapy in Global, including the following market information:

Global Cell Therapy and Acellular Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cell Therapy and Acellular Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cell Therapy and Acellular Therapy include Aegle Therapeutics Corp, ArunA Biomedical, Capricor Therapeutics, Inc., Codiak BioSciences, Inc., Direct Biologics, LLC, EV Therapeutics, Inc., Evox Therapeutics Ltd, Exogenus Therapeutics and Invitrx Therapeutics, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Therapy and Acellular Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cell Therapy and Acellular Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cell Therapy and Acellular Therapy Market Segment Percentages, by Type, 2021 (%)
  • Cell Therapy
  • Acellular Therapy
Global Cell Therapy and Acellular Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cell Therapy and Acellular Therapy Market Segment Percentages, by Application, 2021 (%)
  • Cardiology
  • Hepatology
  • Neurology
  • Gastroenterology
  • Oncology
Global Cell Therapy and Acellular Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cell Therapy and Acellular Therapy Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cell Therapy and Acellular Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cell Therapy and Acellular Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Aegle Therapeutics Corp
  • ArunA Biomedical
  • Capricor Therapeutics, Inc.
  • Codiak BioSciences, Inc.
  • Direct Biologics, LLC
  • EV Therapeutics, Inc.
  • Evox Therapeutics Ltd
  • Exogenus Therapeutics
  • Invitrx Therapeutics, Inc.
  • Organicell Regenerative Medicine, Inc.
  • Rion LLC
  • Stem Cell Medicine Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cell Therapy and Acellular Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cell Therapy and Acellular Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CELL THERAPY AND ACELLULAR THERAPY OVERALL MARKET SIZE

2.1 Global Cell Therapy and Acellular Therapy Market Size: 2021 VS 2028
2.2 Global Cell Therapy and Acellular Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cell Therapy and Acellular Therapy Players in Global Market
3.2 Top Global Cell Therapy and Acellular Therapy Companies Ranked by Revenue
3.3 Global Cell Therapy and Acellular Therapy Revenue by Companies
3.4 Top 3 and Top 5 Cell Therapy and Acellular Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell Therapy and Acellular Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell Therapy and Acellular Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Cell Therapy and Acellular Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cell Therapy and Acellular Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cell Therapy and Acellular Therapy Market Size Markets, 2021 & 2028
  4.1.2 Cell Therapy
  4.1.3 Acellular Therapy
4.2 By Type - Global Cell Therapy and Acellular Therapy Revenue & Forecasts
  4.2.1 By Type - Global Cell Therapy and Acellular Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Cell Therapy and Acellular Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cell Therapy and Acellular Therapy Market Size, 2021 & 2028
  5.1.2 Cardiology
  5.1.3 Hepatology
  5.1.4 Neurology
  5.1.5 Gastroenterology
  5.1.6 Oncology
5.2 By Application - Global Cell Therapy and Acellular Therapy Revenue & Forecasts
  5.2.1 By Application - Global Cell Therapy and Acellular Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Cell Therapy and Acellular Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cell Therapy and Acellular Therapy Market Size, 2021 & 2028
6.2 By Region - Global Cell Therapy and Acellular Therapy Revenue & Forecasts
  6.2.1 By Region - Global Cell Therapy and Acellular Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Cell Therapy and Acellular Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cell Therapy and Acellular Therapy Revenue, 2017-2028
  6.3.2 US Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.3.3 Canada Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.3.4 Mexico Cell Therapy and Acellular Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cell Therapy and Acellular Therapy Revenue, 2017-2028
  6.4.2 Germany Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.3 France Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.4 U.K. Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.5 Italy Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.6 Russia Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.4.8 Benelux Cell Therapy and Acellular Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cell Therapy and Acellular Therapy Revenue, 2017-2028
  6.5.2 China Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.5.3 Japan Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.5.4 South Korea Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.5.6 India Cell Therapy and Acellular Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cell Therapy and Acellular Therapy Revenue, 2017-2028
  6.6.2 Brazil Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.6.3 Argentina Cell Therapy and Acellular Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cell Therapy and Acellular Therapy Revenue, 2017-2028
  6.7.2 Turkey Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.7.3 Israel Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Cell Therapy and Acellular Therapy Market Size, 2017-2028
  6.7.5 UAE Cell Therapy and Acellular Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Aegle Therapeutics Corp
  7.1.1 Aegle Therapeutics Corp Corporate Summary
  7.1.2 Aegle Therapeutics Corp Business Overview
  7.1.3 Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Major Product Offerings
  7.1.4 Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.1.5 Aegle Therapeutics Corp Key News
7.2 ArunA Biomedical
  7.2.1 ArunA Biomedical Corporate Summary
  7.2.2 ArunA Biomedical Business Overview
  7.2.3 ArunA Biomedical Cell Therapy and Acellular Therapy Major Product Offerings
  7.2.4 ArunA Biomedical Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.2.5 ArunA Biomedical Key News
7.3 Capricor Therapeutics, Inc.
  7.3.1 Capricor Therapeutics, Inc. Corporate Summary
  7.3.2 Capricor Therapeutics, Inc. Business Overview
  7.3.3 Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Major Product Offerings
  7.3.4 Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.3.5 Capricor Therapeutics, Inc. Key News
7.4 Codiak BioSciences, Inc.
  7.4.1 Codiak BioSciences, Inc. Corporate Summary
  7.4.2 Codiak BioSciences, Inc. Business Overview
  7.4.3 Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Major Product Offerings
  7.4.4 Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.4.5 Codiak BioSciences, Inc. Key News
7.5 Direct Biologics, LLC
  7.5.1 Direct Biologics, LLC Corporate Summary
  7.5.2 Direct Biologics, LLC Business Overview
  7.5.3 Direct Biologics, LLC Cell Therapy and Acellular Therapy Major Product Offerings
  7.5.4 Direct Biologics, LLC Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.5.5 Direct Biologics, LLC Key News
7.6 EV Therapeutics, Inc.
  7.6.1 EV Therapeutics, Inc. Corporate Summary
  7.6.2 EV Therapeutics, Inc. Business Overview
  7.6.3 EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Major Product Offerings
  7.6.4 EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.6.5 EV Therapeutics, Inc. Key News
7.7 Evox Therapeutics Ltd
  7.7.1 Evox Therapeutics Ltd Corporate Summary
  7.7.2 Evox Therapeutics Ltd Business Overview
  7.7.3 Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Major Product Offerings
  7.7.4 Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.7.5 Evox Therapeutics Ltd Key News
7.8 Exogenus Therapeutics
  7.8.1 Exogenus Therapeutics Corporate Summary
  7.8.2 Exogenus Therapeutics Business Overview
  7.8.3 Exogenus Therapeutics Cell Therapy and Acellular Therapy Major Product Offerings
  7.8.4 Exogenus Therapeutics Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.8.5 Exogenus Therapeutics Key News
7.9 Invitrx Therapeutics, Inc.
  7.9.1 Invitrx Therapeutics, Inc. Corporate Summary
  7.9.2 Invitrx Therapeutics, Inc. Business Overview
  7.9.3 Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Major Product Offerings
  7.9.4 Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.9.5 Invitrx Therapeutics, Inc. Key News
7.10 Organicell Regenerative Medicine, Inc.
  7.10.1 Organicell Regenerative Medicine, Inc. Corporate Summary
  7.10.2 Organicell Regenerative Medicine, Inc. Business Overview
  7.10.3 Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Major Product Offerings
  7.10.4 Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.10.5 Organicell Regenerative Medicine, Inc. Key News
7.11 Rion LLC
  7.11.1 Rion LLC Corporate Summary
  7.11.2 Rion LLC Business Overview
  7.11.3 Rion LLC Cell Therapy and Acellular Therapy Major Product Offerings
  7.11.4 Rion LLC Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.11.5 Rion LLC Key News
7.12 Stem Cell Medicine Ltd.
  7.12.1 Stem Cell Medicine Ltd. Corporate Summary
  7.12.2 Stem Cell Medicine Ltd. Business Overview
  7.12.3 Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Major Product Offerings
  7.12.4 Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Revenue in Global Market (2017-2022)
  7.12.5 Stem Cell Medicine Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Cell Therapy and Acellular Therapy Market Opportunities & Trends in Global Market
Table 2. Cell Therapy and Acellular Therapy Market Drivers in Global Market
Table 3. Cell Therapy and Acellular Therapy Market Restraints in Global Market
Table 4. Key Players of Cell Therapy and Acellular Therapy in Global Market
Table 5. Top Cell Therapy and Acellular Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell Therapy and Acellular Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell Therapy and Acellular Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell Therapy and Acellular Therapy Product Type
Table 9. List of Global Tier 1 Cell Therapy and Acellular Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell Therapy and Acellular Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell Therapy and Acellular Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell Therapy and Acellular Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell Therapy and Acellular Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell Therapy and Acellular Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell Therapy and Acellular Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell Therapy and Acellular Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Aegle Therapeutics Corp Corporate Summary
Table 31. Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Product Offerings
Table 32. Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 33. ArunA Biomedical Corporate Summary
Table 34. ArunA Biomedical Cell Therapy and Acellular Therapy Product Offerings
Table 35. ArunA Biomedical Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 36. Capricor Therapeutics, Inc. Corporate Summary
Table 37. Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Product Offerings
Table 38. Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Codiak BioSciences, Inc. Corporate Summary
Table 40. Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Product Offerings
Table 41. Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 42. Direct Biologics, LLC Corporate Summary
Table 43. Direct Biologics, LLC Cell Therapy and Acellular Therapy Product Offerings
Table 44. Direct Biologics, LLC Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 45. EV Therapeutics, Inc. Corporate Summary
Table 46. EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Product Offerings
Table 47. EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Evox Therapeutics Ltd Corporate Summary
Table 49. Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Product Offerings
Table 50. Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Exogenus Therapeutics Corporate Summary
Table 52. Exogenus Therapeutics Cell Therapy and Acellular Therapy Product Offerings
Table 53. Exogenus Therapeutics Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Invitrx Therapeutics, Inc. Corporate Summary
Table 55. Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Product Offerings
Table 56. Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Organicell Regenerative Medicine, Inc. Corporate Summary
Table 58. Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Product Offerings
Table 59. Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 60. Rion LLC Corporate Summary
Table 61. Rion LLC Cell Therapy and Acellular Therapy Product Offerings
Table 62. Rion LLC Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Stem Cell Medicine Ltd. Corporate Summary
Table 64. Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Product Offerings
Table 65. Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Cell Therapy and Acellular Therapy Segment by Type in 2021
Figure 2. Cell Therapy and Acellular Therapy Segment by Application in 2021
Figure 3. Global Cell Therapy and Acellular Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell Therapy and Acellular Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell Therapy and Acellular Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell Therapy and Acellular Therapy Revenue in 2021
Figure 8. By Type - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 12. US Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 24. China Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell Therapy and Acellular Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell Therapy and Acellular Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Aegle Therapeutics Corp Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. ArunA Biomedical Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Capricor Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Codiak BioSciences, Inc. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Direct Biologics, LLC Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. EV Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Evox Therapeutics Ltd Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Exogenus Therapeutics Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Invitrx Therapeutics, Inc. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Organicell Regenerative Medicine, Inc. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Rion LLC Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Stem Cell Medicine Ltd. Cell Therapy and Acellular Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications